...
首页> 外文期刊>Journal of pediatric and adolescent gynecology >Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity.
【24h】

Homocysteine and ghrelin link with polcystic ovary syndrome in relation to obesity.

机译:同型半胱氨酸和生长激素释放肽与肥胖相关的多囊卵巢综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: Elevated levels of plasma homocysteine and depressed ghrelin levels have been found to be associated with insulin resistance in a number of clinical situations, such as polycystic ovary syndrome. This study was designed to determine the relationship of plasma homocysteine and ghrelin levels with obesity in polycystic ovary syndrome. MATERIAL AND METHODS: Forty-four adolescents and young women (24 lean, 20 obese) 16-21 years old with polycystic ovary syndrome and age matched 20 healthy adolescents and young women were participated the study. Fasting samples were collected for serum vitamin B12, folate, plasma total homocysteine and ghrelin levels. Serum levels of follicle-stimulating hormone, luteinizing hormone, dehydroepiandrosterone sulfate, insulin, 17-hydroxyprogesterone, free testosterone, sex-hormone binding globulin were measured. Also, serum concentrations of total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides were determined. Oral glucose tolerance test was done, and HOMA-IR index was used to define insulin resistance. RESULTS: Plasma total homocysteine levels were significantly higher in women with polycystic ovary syndrome and their plasma ghrelin levels were depressed compared to control group (P < 0.05). Obese adolescents with polycystic ovary syndrome had more depressed plasma ghrelin levels compared to lean ones (P < 0.05). Homocysteine levels didn't correlate with body mass index, but positively correlated with insulin resistance (P < 0.05). CONCLUSION: Elevated plasma homocysteine levels in polycystic ovary syndrome was independent from obesity. Adversely ghrelin levels were depressed with polycystic ovary syndrome in relation to obesity.
机译:目的:在许多临床情况下,如多囊卵巢综合征,血浆高半胱氨酸水平升高和生长素释放肽水平降低与胰岛素抵抗相关。本研究旨在确定多囊卵巢综合征中血浆同型半胱氨酸和生长素释放肽水平与肥胖的关系。材料与方法:44名16-21岁的多囊卵巢综合征,年龄相匹配的健康的青少年和年轻妇女(24例,肥胖,20肥胖)参加了研究。收集空腹样品的血清维生素B12,叶酸,血浆总高半胱氨酸和生长素释放肽水平。测定血清中的促卵泡激素,促黄体激素,硫酸脱氢表雄酮,胰岛素,17-羟孕酮,游离睾丸激素,性激素结合球蛋白的水平。此外,测定了总胆固醇,高密度脂蛋白胆固醇,低密度脂蛋白胆固醇,甘油三酸酯的血清浓度。进行口服葡萄糖耐量测试,并使用HOMA-IR指数定义胰岛素抵抗。结果:多囊卵巢综合征女性血浆总同型半胱氨酸水平显着升高,血浆生长素释放肽水平低于对照组(P <0.05)。肥胖的多囊卵巢综合征青少年的血浆生长素释放肽水平低于瘦人(P <0.05)。同型半胱氨酸水平与体重指数不相关,但与胰岛素抵抗呈正相关(P <0.05)。结论:多囊卵巢综合征的血浆同型半胱氨酸水平升高与肥胖无关。与肥胖有关的多囊卵巢综合征使生长激素释放肽水平降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号